We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Fibromyalgia in Israel

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01203865
Recruitment Status : Unknown
Verified October 2011 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Recruiting
First Posted : September 16, 2010
Last Update Posted : October 12, 2011
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The prevalence of fibromyalgia syndrome in the Israeli population is of importance fro planning resource allocation of medical expenditure as well as for identifying demographic and ethnic differences of this unique population compared with other western samples. In the current study the investigators aim at estimating the prevalence of fibromyalgia in this population. For this purpose a two - stage process will be used. First, a population survey will be conducted by telephone, screening for widespread pain and fatigue in the general population. This survey will use the London Fibromyalgia Epidemiology Study Screening Questionnaire. Second, a sample of patients attending the rheumatology clinic will be surveyed with this tool and will be examined in order to determine the actual proportion of patients fulfilling ACR criteria for fibromyalgia. This will enable us to calculate the positive predictive value of the London Fibromyalgia Epidemiology Study Screening Questionnaire in our population and hence to calculate the prevalence of fibromyalgia in the population.

Condition or disease
Fibromyalgia

Study Design

Study Type : Observational
Estimated Enrollment : 1200 participants
Official Title: Prevalence of Fibromyalgia in Israel
Study Start Date : October 2010
Estimated Primary Completion Date : November 2011
Estimated Study Completion Date : March 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fibromyalgia
U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Prevalence of fibromyalgia in the Israeli population [ Time Frame: 9 months ]

Secondary Outcome Measures :
  1. Demographic data on fibromyalgia patients [ Time Frame: 9 months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Telephone survey - general population over age 18 Rheumatology patients - patients attending the rheumatology clinic for any reason
Criteria

Inclusion Criteria:

  • Individuals over 18 who consent to answer the survey questions
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01203865


Contacts
Contact: Jacob N Ablin, MD 972-3-6973668 jacobab@tasmc.health.gov.il

Locations
Israel
Tel Aviv SOurasky Medical center Recruiting
Tel Aviv, Israel
Contact: Jacob N Ablin, MD    972-3-6973668    jacobab@tasmc.health.gov.il   
Principal Investigator: Jacob N Ablin, MD         
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Pfizer
Investigators
Principal Investigator: Jacob N Ablin, MD Tel-Aviv Sourasky Medical Center
More Information

Publications:
Responsible Party: Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT01203865     History of Changes
Other Study ID Numbers: 0303-10-TLV
WS573984 ( Other Grant/Funding Number: Pfizer Inc. )
First Posted: September 16, 2010    Key Record Dates
Last Update Posted: October 12, 2011
Last Verified: October 2011

Keywords provided by Tel-Aviv Sourasky Medical Center:
Fibromyalgia
Fatigue

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases